13F Holdings
中文EN

ICL ICL Group Ltd. IFRS Annual reports only

Agricultural Chemicals · NYSE · SEC CIK 941221 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY4.6%
TTM net income YoY-44.5%
TTM EPS YoY-43.8%
Revenue 3-yr CAGR-10.6%
Net income 3-yr CAGR-52.9%

Margins

Gross margin30.6%
Operating margin8.1%
Net margin3.2%
FCF margin—
EBITDA margin18.3%

Returns

ROE3.9%
ROA1.9%
ROIC (approx.)4.8%
Asset turnover0.60x

Leverage & solvency

Liabilities / assets49.7%
Debt / equity0.39x
Current ratio1.33x
Interest coverage4.96x

Cash quality & payout

Operating cash flow / net income4.67x
Accruals ratio-7.0%
Payout ratio99.1%
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$7.15B$6.84B$7.54B$10.02B$6.96B
Cost of revenue$4.97B$4.58B$4.87B$4.98B$4.34B
Gross profit$2.19B$2.26B$2.67B$5.03B$2.61B
R&D expense$70.00M$69.00M$71.00M$68.00M$64.00M
SG&A expense$299.00M$259.00M$260.00M$291.00M$276.00M
Operating income$580.00M$775.00M$1.14B$3.52B$1.21B
Interest expense$117.00M$122.00M$259.00M$327.00M$216.00M
Pretax income$441.00M$636.00M$974.00M$3.40B$1.09B
Income tax$161.00M$172.00M$287.00M$1.19B$260.00M
Net income$226.00M$407.00M$647.00M$2.16B$783.00M
EBITDA$1.31B$1.39B$1.68B$4.01B$1.69B
EPS (basic)0.180.320.501.680.61
EPS (diluted)0.180.320.501.670.60
Weighted avg. shares (diluted)1.29B1.29B1.29B1.29B1.29B
Balance sheet
Cash & equivalents$291.00M$327.00M$420.00M$417.00M$473.00M
Receivables$1.36B$1.26B$1.38B$1.58B$1.42B
Inventory$1.93B$1.63B$1.70B$2.13B$1.57B
Current assets$4.16B$3.59B$4.03B$4.55B$3.91B
PP&E, netmay include right-of-use assets (IFRS)$6.79B$6.46B$6.33B$5.97B$5.75B
Total assets$12.41B$11.32B$11.63B$11.75B$11.08B
Current liabilities$3.13B$2.33B$2.64B$2.61B$2.61B
Short-term debt$437.00M$108.00M$575.00M$199.00M$250.00M
Long-term debt$1.88B$1.91B$1.83B$2.31B$2.44B
Total debt$2.32B$2.02B$2.40B$2.51B$2.69B
Total liabilities$6.17B$5.33B$5.59B$6.04B$6.34B
Shareholders' equity$5.98B$5.72B$5.77B$5.46B$4.53B
Net debt$2.03B$1.69B$1.98B$2.09B$2.21B
Cash flow statement
Operating cash flow$1.06B$1.47B$1.71B$2.13B$1.06B
Investing cash flow-$915.00M-$694.00M-$853.00M-$747.00M-$579.00M
Financing cash flow-$195.00M-$846.00M-$837.00M-$1.42B-$244.00M
Depreciation & amortization$726.00M$610.00M$536.00M$498.00M$484.00M
Stock-based compensation———$0$0
Dividends paid$224.00M$251.00M$474.00M$1.17B$276.00M

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.